Sign Up for a Free Account
  • Updated 03.08.2021
  • Released 02.23.1999
  • Expires For CME 03.08.2024

Intravenous immune globulin

Introduction

Historical note and terminology

High-dose intravenous immune globulin has been used for the treatment of autoimmune disorders since 1981, starting with idiopathic thrombocytopenic purpura (22). Although it has been used extensively in neurology during the past decade, some controversies remain about its use and mechanism of action.

Intravenous immune globulin is a purified polyvalent preparation from multiple donor plasma containing all antibodies in a concentrated form with a proportion of IgG of more than 95%. Gamunex®, 10% caprylate-chromatography purified IVIG, is an FDA-approved product.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125